By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Merrimack Pharmaceuticals Inc. 

101 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-441-1000 Fax: 617-491-1386


Start Up


Dyax Corp.  Antibody phage display

Company News
Merrimack (MACK) Debuts New Website 9/25/2015 12:08:19 PM
Merrimack (MACK) Ramps Up Sales Force in Anticipation of Regulatory Approval of Pancreatic Cancer Drug 9/9/2015 6:40:46 AM
Merrimack (MACK) Reports Second Quarter 2015 Financial Results 8/11/2015 7:54:46 AM
Merrimack (MACK) Names Dr. Yasir Al-Wakeel As Chief Financial Officer And Head Of Corporate Development 8/6/2015 7:35:41 AM
Merrimack (MACK) Announces Timing Of Second Quarter 2015 Investor Conference Call 8/3/2015 8:09:10 AM
Merrimack (MACK) Release: U.S. FDA Grants Priority Review For MM-398 New Drug Application 6/25/2015 6:30:00 AM
Merrimack (MACK) Announces The Addition Of John M. Dineen, Former CEO Of GE Healthcare, To Its Board Of Directors 6/16/2015 10:28:13 AM
Merrimack (MACK) Announces Expansion Of MM-398 (nal-IRI) Imaging Study To Patients With Metastatic Breast Cancer 6/12/2015 6:41:49 AM
Merrimack (MACK) Announces Data From An Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile For MM-398 In High-Grade Glioma 6/2/2015 6:16:46 AM
Battle of the Biotech Bands: Momenta (MNTA), PerkinElmer (PKI), Ironwood (IRWD) Will Try to Take Merrimack (MACK)'s Rock Crown 5/19/2015 9:17:02 AM